Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.70 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.59 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.38 |
| ▸ | FEN1 | P39748 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4969015 | 0.98 | CA2 (0.67) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL564371 | 0.86 | CA2 (0.50) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| Hydrazine SCHEMBL4336034 | 0.83 | CA2 (0.90) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| Methylamine SCHEMBL27452203 | 0.83 | CA2 (0.90) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL38598 | 0.83 | CA2 (1.00) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| Hydrazine SCHEMBL28112820 | 0.81 | CA2 (0.85) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| Hydrochloric Acid SCHEMBL7076174 | 0.80 | CA2 (0.94) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL31622310 | 0.80 | CA2 (0.94) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL29189109 | 0.80 | CA2 (0.94) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL22444875 | 0.80 | CA2 (0.94) | CA2GABRA1GABRB2ALOX12ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10920017-B2 | Polyimide resin and resin composition | KANEKA CORPORATION (JP) | 2021-02-16 | — | — | US | disclosed |
| US-20190263968-A1 | POLYIMIDE RESIN AND RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2019-08-29 | — | — | US | disclosed |
| US-10175574-B2 | Coloring composition, and cured film, color filter, pattern forming method, method for manufacturing color filter, solid-state imaging device, image display device, and dye multimer, each using the coloring composition | FUJIFILM CORPORATION (JP) | 2019-01-08 | — | — | US | disclosed |
| EP-2238186-B1 | ETHYLENE/ALPHA-OLEFIN BLOCK INTERPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-11-28 | — | — | EP | disclosed |
| CN-105142605-B | 1, 2-alkane polyol-containing composition | 大阪有机化学工业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| US-20180095374-A1 | MIXTURE, TONER, AND DISPERSION | CANON KABUSHIKI KAISHA (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20180095374-A1 | MIXTURE, TONER, AND DISPERSION | CANON KABUSHIKI KAISHA (JP) | 2018-04-05 | — | — | US | disclosed |
| US-9795549-B2 | 1,2-alkane polyol-containing composition | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2017-10-24 | — | — | US | disclosed |
| US-9671687-B2 | Coloring composition, cured film, color filter, method for manufacturing color filter, solid-state imaging device, and image display device | FUJIFILM CORPORATION (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160327858-A1 | COLORING COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-11-10 | — | — | US | disclosed |
| US-20160327858-A1 | COLORING COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-11-10 | — | — | US | disclosed |
| US-20160045414-A1 | 1,2-ALKANE POLYOL-CONTAINING COMPOSITION | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2016-02-18 | — | — | US | disclosed |
| EP-2985017-A1 | 1,2-ALKANE POLYOL-CONTAINING COMPOSITION | Osaka Organic Chemical Ind., Ltd. (JP) | 2016-02-17 | — | — | EP | disclosed |
| US-20160004154-A1 | RADIATION-SENSITIVE COLORED COMPOSITIONS, CURED COLORED FILMS, COLOR FILTERS, PROCESSES FOR FORMING COLORED PATTERNS, PROCESSES FOR PREPARING COLOR FILTERS, SOLID-STATE IMAGE SENSORS AND LIQUID CRYSTAL DISPLAY DEVICES | FUJIFILM CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
| CN-105142605-A | 1, 2-alkane polyol-containing composition | OSAKA ORGANIC CHEM IND | 2015-12-09 | — | — | CN | disclosed |
| US-6969711-B2 | Cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2005-11-29 | — | — | US | disclosed |
| EP-0987254-B1 | NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME | KOWA CO (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
| EP-0987254-A1 | NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME | Kowa Co., Ltd. (JP) | 2000-03-22 | — | — | EP | disclosed |
| US-4208513-A | Benzoxazolyl-phenylstilbenes, processes for producing them, and their use as optical brighteners | CIBA-GEIGY CORPORATION (US) | 1980-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | LCAT, ACAT2, ACAT1 | CA2 726/4885GABRA1 3225/4885GABRB2 3687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.